vimarsana.com

Latest Breaking News On - Mitochondrial encephalopathy lactic acidosis - Page 1 : vimarsana.com

Thiogenesis Announces Closing of Final Tranche in $4 5 Million Non-Brokered Private Placement

Thiogenesis Therapeutics, Corp. is very pleased to announce that, further to its news release of December 18, 2023, it has closed a second and final tranche of its non-brokered private placement,.

Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation

Further to its news release of November 20, 2023, Thiogenesis Therapeutics, Corp. is very pleased to announce that it has closed a non-brokered private placement through the issuance of 5,584,167.

Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation

Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thiogenesis Announces Addition of Dr Vince Stanton Jr to Its Scientific Advisory Board

San Diego, California (Newsfile Corp. - November 27, 2023) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing sulfur-containing therapeutics for unmet pediatric diseases, today announced the addition of Vincent Stanton Jr., MD to its Scientific Advisory Board ("SAB"). Dr. Stanton was a co-founder of Thiogenesis Therapeutics, Inc., dating back to February 2016.Dr. Vincent Stanton Jr., MD is an entrepreneur and consulta

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.